Navigation Links
Oncolytics Biotech(R) Inc. Completes Lyophilization Process for REOLYSIN(R)
Date:7/20/2009

CALGARY, July 20 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY) announced today that it has successfully completed its lyophilization (freeze-drying) formulation development program for REOLYSIN(R).

"This is the final step in the development of our manufacturing process for REOLYSIN," said Dr. Matt Coffey, Chief Operating Officer for Oncolytics. "Lyophilized product is the standard end use formulation for commercial use of the product."

The lyophilization program was completed in cooperation with the National Research Council Biotechnology Research Institute (NRC-BRI) of Montreal, Canada and Lyophilization Technology, Inc. of Ivyland, Pennsylvania.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I/II and Phase II human trials using REOLYSIN, its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit www.oncolyticsbiotech.com.

About Lyophilization

Lyophilization (or freeze-drying) is a dehydration process typically used to preserve a perishable material or make the material more convenient for transport and storage. Pharmaceutical companies often use lyophilization to increase the shelf life of products, such as vaccines and other injectables. By removing the water from the material and sealing the material in a vial, the material can be easily stored, shipped, and later reconstituted to its original form for injection.

This press release contains forward-looking statements, within the meaning of
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Oncolytics Biotech(R) Inc. Research Collaborators Present Glioma Reovirus Research at ASV Annual Meeting
2. Oncolytics Biotech(R) Inc. Completes Patient Enrolment in U.K. Combination REOLYSIN(R) and Paclitaxel/Carboplatin Head and Neck Cancer Trial
3. Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meeting
4. Oncolytics Biotech(R) Inc.s Research Collaborators to Present Data on REOLYSIN(R) Clinical Trials at ASCO Conference
5. Oncolytics(R) Biotech Inc. Completes Patient Enrolment in U.S. Phase 2 Sarcoma Study
6. Oncolytics Biotech(R) Inc. Announces 2009 First Quarter Results
7. Oncolytics Biotech(R) Inc. Announces Details of 2009 Annual Shareholder Meeting
8. Media Advisory - Oncolytics Biotech(R) Inc. to Present at BioFinance 2009
9. Oncolytics Biotech(R) Inc. Announces Positive Results of U.K. Phase II REOLYSIN(R) and Radiation Combination Clinical Trial
10. Oncolytics Biotech(R) Inc. Completes Enrolment in Combination REOLYSIN(R)/Gemcitabine Trial
11. Oncolytics Biotech(R) Inc. Collaborators Present Reovirus Research at Replicating Oncolytic Virus Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... SHENZHEN , Cina, 22 luglio 2014 ... di BGI, la maggiore organizzazione di genomica del mondo, ... di sequenziamento dell,intero esoma umano con base la piattaforma ... Complete Genomics, molto apprezzata nel settore per essere in ... 99.999% di precisione e una rilevazione altamente sensibile di ...
(Date:7/22/2014)...  Semler Scientific, Inc. (Nasdaq: SMLR ... that develops patented products that assist healthcare providers ... announced that it will report second quarter 2014 ... markets on July 25, 2014. Doug Murphy-Chutorian, M.D., chief executive ... at 11 a.m. EDT, July 25, 2014. The ...
(Date:7/22/2014)... Jersey , 22. Juli 2014 ... Life-Sciences-Industrie, hat die Ernennung von Marcus Bergler zum ... Herr Bergler hat die europäischen kommerziellen Aktivitäten von ... Bevor er sich Qforma anschloss, war er in ... Customer Information, als Vertriebsteam-Leiter Deutschland bei IMS Health ...
(Date:7/21/2014)... 21, 2014 With a larger, ... the new Cole-Parmer® Digital Gear Pump Drive ... to operate for automated process applications. , Simply ... The batch count function counts down and displays ... tracks amount dispensed across multiple cycles. View the ...
Breaking Biology Technology:BGI Tech lancia un servizio di sequenziamento dell'intero esoma umano sulla piattaforma avanzata di Complete Genomics 2Semler to Report Second Quarter 2014 Financial Results and Host Conference Call on July 25, 2014 2Qforma gibt Schaffung des neuen Postens als General Manager in Europa bekannt 2New Easy-View Cole-Parmer Digital Gear Pump Drive Makes Performance Monitoring Effortless 2
... Russell J. Buono and Paul J. Linser, Whitney Marine,Laboratory, ... , , ... a powerful tool , in the study ... of microinjection of foreign DNA into fertilized embryos is tedious and , ...
, , , , , , , back to top...
... Mortimer, Human Genome Center, Division,of Cell and Molecular Biology, Lawrence Berkeley Laboratory,Berkeley, California ... Introduction , ... been performed by a PEG-spheroplast procedure. ... is complicated, often unreliable, and transformation efficiencies are , ...
Cached Biology Technology:Transgenic Zebrafish by Electroporation 2Transgenic Zebrafish by Electroporation 3Transgenic Zebrafish by Electroporation 4Transgenic Zebrafish by Electroporation 5Electroporation of Yeast Artificial Chromosomes 2Electroporation of Yeast Artificial Chromosomes 3Electroporation of Yeast Artificial Chromosomes 4
(Date:7/22/2014)... contrast to their negative reputation as disease causing ... evolutionary functions that help to shape the world ... report by the American Academy of Microbiology. , ... all life forms on the planet, from contributing ... driving major speciation events," states Marilyn Roossinck of ...
(Date:7/22/2014)... multinational, collaborative effort, researchers from the Icahn School of ... locations in the human genome associated with the risk ... on any psychiatric disorder to date, conducted with 80,000 ... point to biological mechanisms and pathways that may underlie ... the disorder, which has seen little innovation in drug ...
(Date:7/22/2014)... as a world-famous vacation spot with natural tourism resources, a ... The Korea Institute of Geoscience and Mineral Resources (KIGAM) indicated ... volcanic eruption was evident 5,000 years ago. That is the ... spewed out of a volcano 5,000 years ago in the ... the whole peninsula. , The research team led by Dr. ...
Breaking Biology News(10 mins):Report on viruses looks beyond disease 2Mount Sinai scientists and international team shed new light on schizophrenia 2Mount Sinai scientists and international team shed new light on schizophrenia 3Jeju Island is a live volcano 2
... than females are born worldwide every year. In recent decades, ... there has been an apparent decline in the ratio of ... Denmark, England, Germany, Japan and the United States. That has ... influence the probability of giving birth to a baby boy ...
... a pollen allergy, an 18-acre ragweed field sounds like ... environmental engineering researchers at The Johns Hopkins University, the ... how the troublesome weeds grow, reproduce and scatter their ... with a mix of high-tech and low-tech tools, could ...
... CORVALLIS, Ore. Generations of studies on vitamin E ... has demonstrated that the levels of this micronutrient necessary ... that have been commonly used in clinical trials. ... Biology and Medicine, researchers concluded that the levels of ...
Cached Biology News:Weight gain between first and second pregnancies associated with increased odds of male second child 2Ragweed research is nothing to sneeze at 2Ragweed research is nothing to sneeze at 3Ragweed research is nothing to sneeze at 4Vitamin E trials 'fatally flawed' 2Vitamin E trials 'fatally flawed' 3
... Agilent Technologies introduces an ... Series ICP-MS for Windows 2000 ... (OS). From September 2003, all ... be controlled by the new ...
... handy dispensers save space and organize ... other garb. They are the perfect ... used in labs, processing and manufacturing. ... and the particles they attract. Many ...
... critical to the maintenance of appropriate ... as important and diverse as those ... and stress response, antigen presentation, modulation ... channels, cell cycle regulation, transcription, and ...
... Normal Pooled Human Serum • Human ... who are found to be negative by ... (s) (HIV-1Ag), Antibodies to Human Immunodeficiency Virus ... Nonreactive for Hepatitis B Surface Antigen (HbsAg) ...
Biology Products: